ACCESS Newswire Reports Second Quarter 2025 Results
Operational Performance: ACCESS Newswire reported a 3% increase in revenue to $5.6 million for Q2 2025, alongside a significant rise in adjusted EBITDA to $836,000, reflecting improved operational efficiencies and a positive cash flow from operations of $135,000.
Subscription Growth: The company continues to transition to a subscription-based model, with the number of subscription customers increasing to 971, contributing to a gross margin of 76% and a return to mid-teen percentages of adjusted EBITDA relative to revenue.
Trade with 70% Backtested Accuracy
Analyst Views on ACCS
About ACCS
About the author
ACCESS Newswire Inc. (ACCS) Surpasses Q3 Earnings and Revenue Projections
Earnings Performance: ACCESS Newswire Inc. reported quarterly earnings of $0.20 per share, exceeding the Zacks Consensus Estimate of $0.15, marking a 33.33% earnings surprise. However, the company has only surpassed consensus EPS estimates once in the last four quarters.
Revenue Insights: The company generated revenues of $5.72 million for the quarter, slightly above the Zacks Consensus Estimate but down from $6.95 million a year ago. ACCESS has also topped revenue estimates just once in the past four quarters.
Stock Outlook: ACCESS Newswire's stock has underperformed the market with a 0.5% decline since the start of the year, compared to the S&P 500's 16.2% gain. The stock currently holds a Zacks Rank #3 (Hold), indicating expected performance in line with the market.
Industry Context: The Media Conglomerates industry, to which ACCESS belongs, is ranked in the bottom 39% of Zacks industries, suggesting potential challenges ahead. Investors are advised to monitor earnings estimate revisions and industry outlooks for better stock performance insights.
Earnings Report Ahead of Market Opening for November 11, 2025: SE, AU, PVLA, DAVA, BWAY, CRNT, PODC, ACCS, WKHS
Earnings Reports Overview: Several companies, including Sea Limited, AngloGold Ashanti, and Palvella Therapeutics, are set to report earnings on November 11, 2025, with varying forecasts indicating significant year-over-year growth for some.
Sea Limited Performance: Sea Limited is expected to report earnings per share of $0.75, reflecting a 212.50% increase from the previous year, with a Price to Earnings ratio of 54.92, indicating strong growth potential compared to industry peers.
AngloGold Ashanti and Brainsway: AngloGold Ashanti anticipates earnings of $1.34 per share (up 139.29%), while Brainsway forecasts $0.11 per share (up 175.00%), both suggesting higher growth than their respective industry averages.
Mixed Results for Other Companies: Companies like Ceragon Networks and Workhorse Group are expected to report lower earnings per share compared to last year, while PodcastOne and ACCESS Newswire show modest increases, highlighting a diverse earnings landscape.
ACCESS Newswire Reports Second Quarter 2025 Results
Operational Performance: ACCESS Newswire reported a 3% increase in revenue to $5.6 million for Q2 2025, alongside a significant rise in adjusted EBITDA to $836,000, reflecting improved operational efficiencies and a positive cash flow from operations of $135,000.
Subscription Growth: The company continues to transition to a subscription-based model, with the number of subscription customers increasing to 971, contributing to a gross margin of 76% and a return to mid-teen percentages of adjusted EBITDA relative to revenue.
This Cytokinetics Analyst Begins Coverage On A Bullish Note; Here Are Top 2 Initiations For Thursday
Analyst Ratings Updates: Barclays analyst Gena Wang initiated coverage on Cytokinetics, Inc. (CYTK) with an Overweight rating and a price target of $5, while Lake Street analyst Jacob Stephan gave ACCESS Newswire Inc. (ACCS) a Buy rating with a price target of $15.
Current Stock Performance: As of Wednesday, Cytokinetics shares closed at $38.00 and ACCESS Newswire shares at $8.65, reflecting significant differences from the analysts' price targets.
Lake Street Initiates Coverage On ACCESS Newswire with Buy Rating, Announces Price Target of $15
Real-time Intelligence: Benzinga Pro offers the fastest news alerts and real-time intelligence for traders to enhance their market performance.
Community Engagement: Over 10,000 serious traders are part of the Benzinga Pro community, benefiting from exclusive stories and accurate stock market insights.
Lake Street Initiates Coverage of ACCESS Newswire (ACCS) with Buy Recommendation
Coverage Initiation and Price Target: Lake Street has initiated coverage of ACCESS Newswire (NYSEAM:ACCS) with a Buy recommendation, projecting an average one-year price target of $13.26/share, indicating a potential upside of 54.64% from its current price of $8.58/share.
Institutional Ownership Trends: There has been a 4.88% increase in the number of funds reporting positions in ACCESS Newswire, with total institutional shares owned rising by 96.35% to 1,461K shares over the last three months.
ACCESS Newswire Inc. (ACCS) Surpasses Q3 Earnings and Revenue Projections
Earnings Performance: ACCESS Newswire Inc. reported quarterly earnings of $0.20 per share, exceeding the Zacks Consensus Estimate of $0.15, marking a 33.33% earnings surprise. However, the company has only surpassed consensus EPS estimates once in the last four quarters.
Revenue Insights: The company generated revenues of $5.72 million for the quarter, slightly above the Zacks Consensus Estimate but down from $6.95 million a year ago. ACCESS has also topped revenue estimates just once in the past four quarters.
Stock Outlook: ACCESS Newswire's stock has underperformed the market with a 0.5% decline since the start of the year, compared to the S&P 500's 16.2% gain. The stock currently holds a Zacks Rank #3 (Hold), indicating expected performance in line with the market.
Industry Context: The Media Conglomerates industry, to which ACCESS belongs, is ranked in the bottom 39% of Zacks industries, suggesting potential challenges ahead. Investors are advised to monitor earnings estimate revisions and industry outlooks for better stock performance insights.
Earnings Report Ahead of Market Opening for November 11, 2025: SE, AU, PVLA, DAVA, BWAY, CRNT, PODC, ACCS, WKHS
Earnings Reports Overview: Several companies, including Sea Limited, AngloGold Ashanti, and Palvella Therapeutics, are set to report earnings on November 11, 2025, with varying forecasts indicating significant year-over-year growth for some.
Sea Limited Performance: Sea Limited is expected to report earnings per share of $0.75, reflecting a 212.50% increase from the previous year, with a Price to Earnings ratio of 54.92, indicating strong growth potential compared to industry peers.
AngloGold Ashanti and Brainsway: AngloGold Ashanti anticipates earnings of $1.34 per share (up 139.29%), while Brainsway forecasts $0.11 per share (up 175.00%), both suggesting higher growth than their respective industry averages.
Mixed Results for Other Companies: Companies like Ceragon Networks and Workhorse Group are expected to report lower earnings per share compared to last year, while PodcastOne and ACCESS Newswire show modest increases, highlighting a diverse earnings landscape.
ACCESS Newswire Reports Second Quarter 2025 Results
Operational Performance: ACCESS Newswire reported a 3% increase in revenue to $5.6 million for Q2 2025, alongside a significant rise in adjusted EBITDA to $836,000, reflecting improved operational efficiencies and a positive cash flow from operations of $135,000.
Subscription Growth: The company continues to transition to a subscription-based model, with the number of subscription customers increasing to 971, contributing to a gross margin of 76% and a return to mid-teen percentages of adjusted EBITDA relative to revenue.
This Cytokinetics Analyst Begins Coverage On A Bullish Note; Here Are Top 2 Initiations For Thursday
Analyst Ratings Updates: Barclays analyst Gena Wang initiated coverage on Cytokinetics, Inc. (CYTK) with an Overweight rating and a price target of $5, while Lake Street analyst Jacob Stephan gave ACCESS Newswire Inc. (ACCS) a Buy rating with a price target of $15.
Current Stock Performance: As of Wednesday, Cytokinetics shares closed at $38.00 and ACCESS Newswire shares at $8.65, reflecting significant differences from the analysts' price targets.
Lake Street Initiates Coverage On ACCESS Newswire with Buy Rating, Announces Price Target of $15
Real-time Intelligence: Benzinga Pro offers the fastest news alerts and real-time intelligence for traders to enhance their market performance.
Community Engagement: Over 10,000 serious traders are part of the Benzinga Pro community, benefiting from exclusive stories and accurate stock market insights.
Lake Street Initiates Coverage of ACCESS Newswire (ACCS) with Buy Recommendation
Coverage Initiation and Price Target: Lake Street has initiated coverage of ACCESS Newswire (NYSEAM:ACCS) with a Buy recommendation, projecting an average one-year price target of $13.26/share, indicating a potential upside of 54.64% from its current price of $8.58/share.
Institutional Ownership Trends: There has been a 4.88% increase in the number of funds reporting positions in ACCESS Newswire, with total institutional shares owned rising by 96.35% to 1,461K shares over the last three months.
